[lu-177]-pnt2002,abiraterone,enzalutamide
pfizer,astellas,point biopharma,janssen
['splash', 'crpc', '$pnt']
$pnt point biopharma provides updated efficacy and safety data from the lead-in cohort of the phase 3 splash trial in mcrpc at esmo congress 2022 45 seconds delayed.
Democratizing insights.

Not investment advice.